1. All Products
  2. ZIDOVUDINE (AZT), 50mg/5ml, oral sol., 240ml, bot.
Public Pricelist

ZIDOVUDINE (AZT), 50mg/5ml, oral sol., 240ml, bot.

https://medicalguidelines.msf.org/en/node/718
https://unicat.msf.org/cat/product/12346
STD DORAYIDO3S-

Valid Article

Former Code(s): -X DORAZYN1019
Article is intended to be used with children (<12 years) ONLY.
6.4.2.1 - Nucleoside/Nucleotide reverse transcriptase inhibitors
Classification of the medicines in groups and subgroups according to their therapeutic use. The classification used by MSF is based on the WHO Model List of Essential Medicines.
J05AF01
Anatomical Therapeutic Chemical Classification according to WHOCC
1525
Thermosensitive codes are defined for storage and transportation temperature requirements of the products.
The product is part of at least one Kit. A kit is a collection of products (medical and/or logistic) that are needed for a certain intervention in emergency. The choice and quantity of the articles reflects the MSF protocols for this specific situation. The use of Kits allows to start an intervention without a detailed evaluation.
OC subscriptions: included in supply or field order tools (e.g. UniField)
SC subscriptions: included in supply or field tools
OC validations: approved for procurement and use by an OC for international or local orders specifying context and activity in Medical Standard Lists (MSL)

This combination does not exist.

Add article to list

   
Create Cancel

Add Kit To Wishlist

   
Create Cancel

ZIDOVUDINE (AZT)

Therapeutic Action

Antiretroviral, nucleoside reverse transcriptase inhibitor (NRTI)

Indications

HIV infection, in combination with other antiretrovirals

Instructions for use

The oral solution is intended for PMTCT or treatment of neonates until they can switch to the preferred treatment option.

When zidovudine is used in association with other antiretrovirals, fixed-dose combinations (FDC) are available:

Storage

Below 25ºC - Protect from sunlight